Classes
DEA Class; OTC
Common Brand Names; Lastacaft
- Antihistamines, Ophthalmic
Description
Topical ophthalmic H1-antagonist
Used for the prevention of ocular pruritus associated with allergic conjunctivitis
Once daily administration
Indications
Indicated for prevention of itching associated with allergic conjunctivitis
Contraindications
Hypersensitivity
Adverse Effects
Ocular
Irritation
Burning
Stinging
Redness
Pruritus
Eye discharge
Eye swelling
Erythema of eyelid
Eyelid edema
Nonocular
Nasopharyngitis
Headache
Influenza
Somnolence
Warnings
To minimize eye injury and contamination of dropper tip and solution, care should be taken not to touch eyelids or surrounding areas with dropper tip of bottle; keep bottle tightly closed when not in use
Keep bottle tightly closed when not in use
Do not use for contact lens–related irritation
Remove contact lenses before instillation
Pregnancy and Lactation
Use of mycophenolate mofetil (MMF) during pregnancy is associated with an increased risk of first-trimester pregnancy loss and an increased risk of multiple congenital malformations in multiple organ systems
There are no data on presence of drug in human milk, or effects on milk production; there are limited data in the National Transplantation Pregnancy Registry on effects of mycophenolate on a breastfed child; studies in rats treated with MMF have shown mycophenolic acid (MPA) to be present in milk
Maximum Dosage
1 drop/day ophthalmic solution in each eye.
1 drop/day ophthalmic solution in each eye.
1 drop/day ophthalmic solution in each eye.
>= 2 years: 1 drop/day ophthalmic solution in each eye.
< 2 years: Safety and efficacy have not been established.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Alcaftadine
ophthalmic solution
- 0.25%